Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001314528 | SCV001505064 | uncertain significance | Transposition of the great arteries, dextro-looped | 2022-05-30 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 2116 of the MED13L protein (p.Ser2116Leu). This variant is present in population databases (rs774432060, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with MED13L-related conditions. ClinVar contains an entry for this variant (Variation ID: 1015642). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV003132400 | SCV003810918 | uncertain significance | Cardiac anomalies - developmental delay - facial dysmorphism syndrome | 2021-03-02 | criteria provided, single submitter | clinical testing |